Total parenteral nutrition is a major risk factor for central venous catheter-related bloodstream infection in colorectal cancer patients receiving postoperative chemotherapy

European Surgical Research

Volumn 41, Issue 4, 2008, Pages 341-345

  Ishizuka, M ^a   Nagata, H ^a   Takagi, K ^a   Kubota, K ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Central venous catheter related bloodstream infection; Risk factors; Total parenteral nutrition

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CATHETER INFECTION; CATHETERIZATION; CENTRAL VENOUS CATHETER; COLORECTAL CANCER; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TOTAL PARENTERAL NUTRITION;

AGED; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 54749135889     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000160181     Document Type: Article

References (13)

1. Veenstra DL, Saint S, Sullivan SD: Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999;282:554-560.
2. Bacuzzi A, Cecchin A, Del Bosco A, et al: Recommendations and reports about central venous catheter-related infection. Surg Infect (Larchmt) 2006;7:65-67.
3. Marra AR, Opilla M, Edmond MB, et al: Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 2007;41:19-28.
4. Raad II, Hohn DC, Gilbreath BJ, et al: Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-238.
5. Mermel LA, McCormick RD, Springman SR, et al: The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91:197-205.
6. Mermel LA, Farr BM, Sherertz RJ, et al: Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-1272.
7. Humar A, Ostromecki A, Direnfeld J, et al: Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000;31:1001-1007.
8. David A, Risitano DC, Mazzeo G, et al: Central venous catheters and infections. Minerva Anestesiol 2005;71:561-564.
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Huges JM: CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-140.
10. Chen HS, Wang FD, Lin M, et al: Risk factors for central venous catheter-related infections in general surgery. J Microbiol Immunol Infect 2006;39:231-236.
11. Dissanaike S, Shelton M, Warner K, et al: The risk for bloodstream infections is associated with increased parenteral caloric intake in patients receiving parenteral nutrition. Crit Care 2007;11:R114.
12. Tacconelli E, Tumbarello M, Pittiruti M, et al: Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. Eur J Clin Microbiol Infect Dis 1997;16:203-209.
13. Alonso-Echanove J, Edwards JR, Richards MJ, et al: Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 2003;24:916-925.